SK Bio-Pharmaceuticals Enters Into a Strategic Alliance With SK Chemicals Co. Ltd.
4/18/2013 11:34:58 AM
More...
|
SK Bio-Pharmaceuticals Announces FDA's Authorization of IND for SKL15508
4/17/2013 11:28:58 AM
More...
|
SK Bio-Pharmaceuticals Announces a Strategic Alliance for Innovative Drug Development With Chinese Biopharmaceutical Companies
3/28/2013 9:59:05 AM
More...
|
SK Bio-Pharmaceuticals Drug Program is Granted Funding Support From Korean Government
12/13/2012 10:24:23 AM
More...
|
SK Bio-Pharmaceuticals Enters into a Licensing Agreement With Hanmi Pharmaceutical, Co., Ltd
5/10/2012 10:40:47 AM
More...
|
SK Bio-Pharmaceuticals and Hanmi Pharmaceutical, Co., Ltd Will Bring Epilepsy Treatment to China
4/25/2012 2:41:37 PM
More...
|
Orphan Drug Designation Granted to SK Bio-Pharmaceuticals’ Carisbamate for the Management of Infantile Spasms
4/20/2012 10:31:46 AM
More...
|
SK Bio-Pharmaceuticals to Initiate Phase 2 Trials in US
3/16/2012 10:15:47 AM
More...
|
SK Bio-Pharmaceuticals Announces New CEO, Dr. Christopher Gallen
3/7/2012 8:11:28 AM
More...
|
SK Bio-Pharmaceuticals Drug Program Wins Funding Support from Korean Government
3/5/2012 7:04:07 AM
More...
|
|